Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcuma xanthorriza Roxb. 10% Cream for Melasma
NCT06153134Phase 1Unknown
- Sponsor
- Universitas Padjadjaran
- Start
- Dec 2023
- Primary completion
- Feb 2024
- Modality
- PE (Plant Extract)
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of curcuma xanthorriza in melasma (2 arms), sponsored by Universitas Padjadjaran. Primary endpoints: Modified Melasma Area and Severity Index at 56 days and Skin Brightness at 56 days. Status: unknown.
02
Drugs
curcuma xanthorriza
03
Conditions
melasma
Beyond the preview
Go deeper on NCT06153134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06153134.